1. Home
  2. GROV vs ANEB Comparison

GROV vs ANEB Comparison

Compare GROV & ANEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Grove Collaborative Holdings Inc.

GROV

Grove Collaborative Holdings Inc.

HOLD

Current Price

$1.29

Market Cap

50.9M

ML Signal

HOLD

Logo Anebulo Pharmaceuticals Inc.

ANEB

Anebulo Pharmaceuticals Inc.

HOLD

Current Price

$1.08

Market Cap

46.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GROV
ANEB
Founded
2016
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Package Goods/Cosmetics
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
50.9M
46.0M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
GROV
ANEB
Price
$1.29
$1.08
Analyst Decision
Buy
Hold
Analyst Count
2
1
Target Price
$1.60
N/A
AVG Volume (30 Days)
37.3K
143.9K
Earning Date
11-13-2025
02-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$180,808,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$3.63
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.02
$0.90
52 Week High
$1.84
$3.42

Technical Indicators

Market Signals
Indicator
GROV
ANEB
Relative Strength Index (RSI) 56.39 26.03
Support Level $1.18 $1.02
Resistance Level $1.26 $1.14
Average True Range (ATR) 0.06 0.10
MACD 0.02 0.03
Stochastic Oscillator 91.15 48.34

Price Performance

Historical Comparison
GROV
ANEB

About GROV Grove Collaborative Holdings Inc.

Grove Collaborative Holdings Inc is engaged in providing consumer products. It offers Cleaning accessories, Home and Pantry, Personal care products, Pets supplements and Other products. It is a sustainability oriented consumer products generator. It use connection with consumers to create and curate authentic, disruptive brands and products. Company builds natural products that perform as well as, many consumer packaged goods (CPG) brands (both conventional and natural), while being healthier for consumers and the planet.

About ANEB Anebulo Pharmaceuticals Inc.

Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing treatments for cannabinoid overdose and substance addiction. Its principal product candidate, ANEB-001 (Selonabant), is designed to rapidly counteract the negative effects of cannabis toxicity, including unintentional cannabis poisoning and acute cannabinoid intoxication. The company is focusing on addressing the unmet medical needs in the treatment of cannabinoid toxicity through various therapies. Anebulo Pharmaceuticals operates in one segment, exclusively in the United States.

Share on Social Networks: